Sudbury company attracts $8M investment to support its leading-edge cancer treatment technology
A Sudbury-based company has received $8 million in private investment to support its work in cancer diagnostic technology.
Rna Diagnostics grew out of work done at Laurentian University and Health Sciences North Research Institute (HSNRI). Dr. Amadeo Parissenti, a scientist and LU professor, has developed technology that allows doctors to tell whether chemotherapy is having an impact on a patient's cancer.
"The RNA disruption assay (RDA), patented by Laurentian University and licensed to Rna Diagnostics in 2010, determines whether a patient is responding to cancer therapy, early during treatment," the company said in a news release Wednesday.
Using RDA, doctors can determine within five weeks of the start of treatment whether chemotherapy is working, allowing doctors to tailor the treatment according to the individual patient's response.
"This means that if a patient’s tumour is not responding to treatment, 80 per cent of ineffective doses and lost time can be avoided," the company said.
Rna Diagnostics has received $8 million in what's known as 'series A' financing from iGan Partners and BDC Capital. Series A financing is private funding that startup companies receive when their product or service shows enough promise to attract investment.
The discovery of RDA was made in 2007 by Parissenti and his research associate, Dr. Baoqing Guo, in their lab at HSNRI. It was patented by Laurentian University in 2010.
Rna Diagnostics’ laboratory is headquartered at HSNRI in Sudbury.
“The continued support of iGan Partners and our current investors, combined with the support of BDC Capital as a new investment partner, is exciting,” John Connolly, president and CEO of Rna Diagnostics, said in the news release.
“The closing of this series A financing will allow us to complete the pivotal validation trial (BREVITY) of the RNA Disruption Assay. BREVITY is currently recruiting patients at over 40 breast cancer centres in Europe and North America.”
Parissenti continues to study the cellular mechanisms involved in RNA disruption with Dr. Carita Lanner and Dr. Tom Kovala of the Northern Ontario School of Medicine in the hopes of finding additional tools to predict or monitor chemotherapy response and outcome in cancer patients.
“Laurentian University is proud to offer its congratulations to Dr. Parissenti and Rna Diagnostics Inc. on this incredible milestone, the investment will provide critical funding to complete the clinical trials and bring to market a technology that will improve cancer treatments worldwide while impacting positively on the quality of life of cancer patients,” Tammy Eger, Laurentian University’s vice-president, research, said in the release.
“A true northern innovation created by outstanding partnerships and collaboration.”
“This is an enormous, expensive problem for cancer centres. Typically, in solid tumors, only 30-40 per cent of patients receive a survival benefit from a given drug regimen,” Connolly added. “Patients with nonresponsive tumours (identified by the RDA) can therefore forgo the ineffective treatment and its side-effects and moved quickly to alternate treatments.”
CTVNews.ca Top Stories
B.C. tenants evicted for landlord's use after refusing large rent increase to take over neighbouring suite
Ashley Dickey and her mother rented part of the same Coquitlam duplex in three different decades under three different landlords.
Mountain guide dies after falling into a crevasse in Banff National Park
A man who fell into a crevasse while leading a backcountry ski group deep in the Canadian Rockies has died.
Expert warns of food consumption habits amid rising prices
A new survey by Dalhousie University's Agri-Food Analytics Lab asked Canadians about their food consumption habits amid rising prices.
MPP Sarah Jama asked to leave Ontario legislature for wearing keffiyeh
MPP Sarah Jama was asked to leave the Legislative Assembly of Ontario by House Speaker Ted Arnott on Thursday for wearing a keffiyeh, a garment which has been banned at Queen’s Park.
Charlie Woods, son of Tiger, shoots 81 in U.S. Open qualifier
Charlie Woods failed to advance in a U.S. Open local qualifying event Thursday, shooting a 9-over 81 at Legacy Golf & Tennis Club.
Ex-tabloid publisher testifies he scooped up possibly damaging tales to shield his old friend Trump
As Donald Trump was running for president in 2016, his old friend at the National Enquirer was scooping up potentially damaging stories about the candidate and paying out tens of thousands of dollars to keep them from the public eye.
Here's why provinces aren't following Saskatchewan's lead on the carbon tax home heating fight
After Prime Minister Justin Trudeau said the federal government would still send Canada Carbon Rebate cheques to Saskatchewan residents, despite Saskatchewan Premier Scott Moe's decision to stop collecting the carbon tax on natural gas or home heating, questions were raised about whether other provinces would follow suit. CTV News reached out across the country and here's what we found out.
Montreal actress calls Weinstein ruling 'discouraging' but not surprising
A Montreal actress, who has previously detailed incidents she had with disgraced Hollywood producer Harvey Weinstein, says a New York Court of Appeals decision overturning his 2020 rape conviction is 'discouraging' but not surprising.
Caleb Williams, Jayden Daniels and Drake Maye make it four NFL drafts with quarterbacks going 1-3
Caleb Williams is heading to the Windy City, aiming to become the franchise quarterback Chicago has sought for decades.